Fanelli, Giuseppe Nicolò
Dal Pozzo, Carlo Alberto
Depetris, Ilaria
Schirripa, Marta
Brignola, Stefano
Biason, Paola
Balistreri, Mariangela
Dal Santo, Luca
Lonardi, Sara
Munari, Giada
Loupakis, Fotios
Fassan, Matteo http://orcid.org/0000-0001-6515-5482
Funding for this research was provided by:
Ministero della Salute (NET-2016-02363853)
Article History
Received: 6 August 2019
Accepted: 20 January 2020
First Online: 29 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Fotios Loupakis had roles as a consultant or advisor for Roche, Bayer, Amgen and Genentech Pharmaceuticals. Sara Lonardi had roles as a consultant or advisor for Amgen, Bayer, Merck Serono and Lilly. She received research funding from Amgen and Merck Serono, and she is part of the speakers’ bureau of Lilly and BMS. Matteo Fassan had roles as a consultant or advisor for Tesaro and Astellas. He received research funding from Astellas and QED. The other authors have no competing interests to declare. The authors declare that they have no competing interests.